1 / 11

Abu Alam Ph.D.

Abu Alam Ph.D. Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July 23, 2008. Locally Acting Oral Drugs. For the Treatment of Gastrointestinal Conditions. Drug Substance. Purity Impurity Molecular Size Solubility (pH 1 to 8) Permeability Degradation

marged
Download Presentation

Abu Alam Ph.D.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Abu Alam Ph.D. Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July 23, 2008

  2. Locally Acting Oral Drugs For the Treatment of Gastrointestinal Conditions

  3. Drug Substance • Purity • Impurity • Molecular Size • Solubility (pH 1 to 8) • Permeability • Degradation • Analytical Method • Specification • Stability

  4. Dosage Form • Formulation • Excipients • Manufacturing process • Dosage form design • Tablet • Capsule • Specifications • Stability

  5. Schematic of GI Transit Oral Dosage Stomach pH 1.2 Duodenum pH 4.5 Elimination Feces Colon pH 7.5 Jejunum pH 6.8

  6. Dissolution Illustrations USP Method I or II pH 1.2 (Sodium Chloride)

  7. Dissolution Illustrations USP Method I or II pH 4.5 (Acetate Buffer)

  8. Dissolution Illustrations USP Method I or II pH 6.8 (Phosphate Buffer)

  9. Schematic of Disposition Oral Dosage Dissolution GI Tract Local Action GI Tract Elimination Feces Systemic Absorption Systemic Toxicity Elimination

  10. Criteria • Not specifically absorbed • Local action • Dissolution is pH independent • Freely available at site of action • No permeation • Vancomycin capsule fits the criteria

  11. Conclusion • Comparative, superimposable dissolution profile • Rate and extent of dissolution are same • In Vivo bioequivalency is unnecessary • Clinical trial to prove safety and efficacy are unnecessary

More Related